Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, November 2007, p. 4111-4117, Vol. 51, No. 11
0066-4804/07/$08.00+0 doi:10.1128/AAC.00584-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
vanD and vanG-Like Gene Clusters in a Ruminococcus Species Isolated from Human Bowel Flora
M.-C. Domingo,1,2
A. Huletsky,1,2
R. Giroux,1
F. J. Picard,1,2 and
M. G. Bergeron1,2*
Centre de Recherche en Infectiologie de l'Université Laval, CHUQ, Pavillon CHUL, Québec, Québec, Canada G1V 4G2,1
Division de Microbiologie, Faculté de Médecine, Université Laval, Québec, Québec, Canada2
Received 3 May 2007/
Returned for modification 14 June 2007/
Accepted 20 August 2007

ABSTRACT
A vancomycin-resistant, anaerobic, gram-positive coccus containing
the
vanD and
vanG-like genes (strain CCRI-16110) was isolated
from a human fecal specimen during a hospital surveillance program
to detect carriers of vancomycin-resistant enterococci. Comparison
of the 16S rRNA gene sequence of strain CCRI-16110 with databases
revealed a potentially novel
Ruminococcus species that was most
similar (<94% identity) to
Clostridium and
Ruminococcus species.
Strain CCRI-16110 was highly resistant to vancomycin and teicoplanin
(MICs of >256 µg/ml). The complete DNA sequence of
the
vanD cluster was most similar (98.2% identity) to that of
Enterococcus faecium BM4339, containing the
vanD1 allele. An
intD gene with 99% identity with that of this
E. faecium strain
was found to be associated with the
vanD gene cluster of this
novel anaerobic bacterium. Strain CCRI-16110 also harbors genes
encoding putative VanS
G, VanG, and VanT
G proteins displaying
56, 73.6, and 55% amino acid sequence identity, respectively,
compared to the corresponding proteins encoded by the
vanG1 and
vanG2 operons of
Enterococcus faecalis BM4518 and N03-0233.
This study reports for the first time an anaerobic bacterium
containing the
vanD gene cluster. This strain also harbors a
partial
vanG-like gene cluster. The presence of
vanD- and
vanG-containing
anaerobic bacteria in the human bowel flora suggests that these
bacteria may serve as a reservoir for the
vanD and
vanG vancomycin
resistance genes.

INTRODUCTION
The glycopeptide antibiotics vancomycin and teicoplanin interfere
with cell wall synthesis in gram-positive bacteria by binding
to the terminal dipeptide
D-alanyl-
D-alanine regions of the
pentapeptide precursors of peptidoglycan side chains. Resistance
to glycopeptide antibiotics was first described for enterococci
(
23,
35) and has now spread worldwide. Six different genes (
vanA,
vanB,
vanC,
vanD,
vanE, and
vanG) have been shown to confer
glycopeptide resistance in enterococci (
7).
The VanD-type resistance is constitutively expressed in enterococci (8, 11) and is characterized by moderate MICs of vancomycin (64 to 128 µg/ml) and teicoplanin (4 to 64 µg/ml). This VanD-type resistance results from the acquisition of the vanRD, vanSD, vanYD, vanHD, vanD, and vanXD cluster of genes, which directs synthesis of peptidoglycan precursors terminating in D-alanyl-D-lactate (11). The vanD gene cluster is located on the chromosome and is not transferable to other enterococci by conjugation in vitro (11). The VanD-type resistance in enterococci is also characterized by the presence of an impaired D-alanyl-D-alanine (Ddl) ligase due to mutations in the chromosomal ligase-encoding gene ddl (10). Although the Ddl ligase is inactive, the VanD-type enterococci are able to grow even in the absence of glycopeptide because the vanD cluster is expressed constitutively as a result of mutations in the VanSD sensor or in the VanRD regulator (10).
The VanG-type resistance in enterococci is characterized by low-level resistance to vancomycin (MIC, 16 µg/ml) and susceptibility to teicoplanin (9). This VanG-type resistance results from the acquisition of the vanUG, vanRG, vanSG, vanYG, vanWG, vanG, vanXYG, and vanTG cluster of genes, which directs synthesis of peptidoglycan precursors terminating in D-alanyl-D-serine (D-Ala-D-Ser) (9).
To date, the vanD and vanG gene clusters have been described only for Enterococcus. However, the complete genome sequence of the Clostridium difficile strain 630 recently revealed the presence of a cluster of genes with high similarity to the vanG cluster in enterococci (32). Moreover, our group has recently described a high prevalence of vanB (4.8%), vanD (37.9%), and vanG (9.3%) genes in fecal specimens which are not associated with vancomycin-resistant enterococci, during a vancomycin-resistant enterococcus surveillance program implemented in two North American hospitals (13).
In this study, we describe for the first time an anaerobic bacterium of the human bowel which is resistant to both vancomycin and teicoplanin and which contains vanD and vanG-like gene clusters.
(This study was presented in part at the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 27 to 30 September 2006.)

MATERIALS AND METHODS
Isolation procedure and identification.
A
vanD-positive rectal specimen, ERV-110, collected from a patient
at the Montreal General Hospital (Québec, Canada) in
2001 (
13) was subcultured several times in brain heart infusion
broth (Difco, Detroit, MI) supplemented with vitamin K (0.001
mg/ml), hemin (0.005 mg/ml),
L-cystine (0.5 mg/ml), sodium lactate
(10 mM), sodium pyruvate (10 mM), vancomycin (10 µg/ml),
and aztreonam (100 µg/ml) under anaerobic conditions at
35 to 37°C. A subculture was then plated on agar medium
containing the same supplement and incubated under the same
anaerobic conditions for 7 days. Colonies were then screened
for the presence of the
vanD gene by PCR. Identification of
the
vanD-positive colony (strain CCRI-16110) was performed by
methods previously described (
15) and with the Rapid ID 32A
system (bioMérieux, Marcy l'Étoile, France). Partial
sequencing of a 1,466-bp region of the gene encoding 16S rRNA
was performed as previously described (
12).
Resistance studies.
MICs of vancomycin and metronidazole were determined by the agar dilution method for anaerobes according to the CLSI (formerly NCCLS) (24), whereas the MIC of teicoplanin was determined by the Etest method (AB Biodisk, Sweden). The medium used for antimicrobial susceptibility testing was brucella agar (Difco, Detroit, MI) supplemented with laked sheep blood, vitamin K (0.001 mg/ml), and hemin (0.005 mg/ml).
Bacterial strains and plasmids.
Enterococcus faecium BM4339 (resistant to vancomycin and teicoplanin and containing the vanD gene cluster) (5) and Enterococcus faecalis JH2-2 (resistant to fusidic acid and rifampin) (18) were obtained from P. Courvalin (Unité des Agents Antibactériens, Institut Pasteur, Paris, France) and from N. Woodford (Health Protection Agency, Collindale, London, United Kingdom), respectively. E. faecium BM4339 was used as a control strain, and E. faecalis JH2-2 was used as recipient in the conjugation experiments. Escherichia coli TOP10 (Invitrogen, Burlington, Ontario, Canada) was used as a host for recombinant plasmids. PCR products were cloned in the vector pCR2.1 using the TOPO TA cloning kit (Invitrogen, Burlington, Ontario, Canada).
Sequencing of the vanD gene cluster.
The primers used to characterize the vanD cluster are described in Table 1. PCRs were performed using standard conditions with purified genomic DNA and the Taq DNA polymerase (Promega, Mississauga, Ontario, Canada) as previously described (20). Purification of the amplification products and sequencing reactions were performed as previously described (20). Comparison with known sequences was carried out using the programs from the GCG package (Wisconsin package version 10.3; Accelrys Inc., San Diego, CA).
View this table:
[in this window]
[in a new window]
|
TABLE 1. PCR primers used in this study to amplify and sequence the vanD and vanG-like clusters from Ruminococcus sp. strain CCRI-16110
|
Sequencing of the vanG-like gene cluster.
PCR amplification using universal primers V1 and V2a (Table
1), which were designed to amplify an internal region of the
genes encoding Ddl ligases and related vancomycin-resistant
proteins (
14), was performed using genomic DNA purified from
strain CCRI-16110. PCR products of the expected size (630 bp)
were purified and cloned in the vector pCR2.1. The inserts from
these recombinant plasmids were sequenced using the universal
M13 forward and M13 reverse primers (Invitrogen). Nucleotide
and deduced amino acid sequences from the cloned 630-bp PCR
product obtained were analyzed by using the BLASTN, TBLASTN,
and BLASTP softwares. Subsequently, the DNA sequence flanking
the 630-bp fragment containing the
vanG-like gene was obtained
by using a combination of PCR amplifications with the DNA Walking
SpeedUp kit (Bio/Can Scientific, Mississauga, Ontario, Canada)
and cloning techniques as previously described (
12). Sequences
obtained by these methods were confirmed by sequencing PCR products
generated after amplification of total genomic DNA from strain
CCRI-16110, using specific primers overlapping the cloned fragments
(Table
1). The Artemis software (
27) was used to analyze and
collate data from the complete sequence.
Phylogenetic analysis of the vanG-like gene from strain CCRI-16110.
To ascertain the phylogenetic position of the deduced protein sequence of the vanG-like ligase gene from strain CCRI-16110, phylogenetic analysis was performed using the deduced amino acid sequences from the Ddl ligases of gram-positive and gram-negative organisms as well as the D-Ala-D-Lac and D-Ala-D-Ser ligases of vancomycin-resistant organisms. Amino acid sequence alignment was performed with CLUSTALW (34). Phylogenetic analysis was carried out by the neighbor-joining method (28) using MEGA version 3.1 (21). The evolutionary distance was generated according to the Jones-Taylor-Thornton matrix for amino acid sequences (19). The tree topology was compared to that obtained by the maximum-parsimony method. Bootstrap values were calculated from 1,000 resamplings to test the robustness of the data and were displayed as percentages.
Filter mating.
To study the transfer by conjugation of the glycopeptide resistance phenotype of strain CCRI-16110, mating on filters was performed as described previously (12). E. faecalis JH2-2 was used as the recipient, while strain CCRI-16110 was used as a donor.
Nucleotide sequence accession numbers.
The GenBank accession numbers for the vanD gene cluster and partial vanG-like gene cluster sequences of strain CCRI-16110 are EF508033 and EF508032, respectively.

RESULTS
Isolation and identification of Ruminococcus sp. strain CCRI-16110 containing vanD.
We isolated a strictly anaerobic, gram-positive coccus (strain
CCRI-16110) from fecal specimen ERV-110. Biochemical tests performed
in triplicate using the Rapid ID 32A system remained negative
for all substrates tested with this system. Analysis of the
partial sequence of its 16S rRNA gene revealed that strain CCRI-16110
was most similar to
Clostridium and
Ruminococcus species (<94%
identity) belonging to the
Clostridium coccoides cluster of
organisms (rRNA cluster XIVa) (
6). Based on these phenotypic
and genotypic analyses, strain CCRI-16110 is a potentially novel
Ruminococcus species. This strain was resistant to vancomycin
and teicoplanin (MICs, >256 µg/ml) and susceptible
to metronidazole (MIC, <0.125 µg/ml).
Characterization of the vanD gene cluster from Ruminococcus sp. strain CCRI-16110.
The vanD gene cluster from Ruminococcus sp. strain CCRI-16110 was characterized to determine its genetic organization. Nucleotide sequence analysis of the vanD gene cluster of this strain showed that the gene order of this cluster was similar to that of known vanD clusters (Fig. 1A). The complete DNA sequence of the CCRI-16110 vanD operon (from vanRD to vanXD, 5,655 bp) exhibited 98% identity with the vanD1 operon (accession number AF130997), 97% identity with the vanD3 operon (accession number AF175293), 95% identity with the vanD2 operon (accession number AF153050), 93% identity with the vanD5 operon (accession number AY489045), and 89% identity with the vanD4 operon (accession number AY082011). The amino acid sequences of VanRD, VanSD, VanHD, and VanXD of the vanD operon from this Ruminococcus strain were most similar to those of the vanD1 operon from E. faecium BM4339, while the amino acid sequences of VanYD and VanD were most similar to those of the vanD3 operon from E. faecium N97-330 (Table 2). The H, N, G1, F, and G2 conserved motifs found in histidine kinase proteins were present in the VanSD sensor of strain CCRI-16110 (10). Comparison of the sequence of the VanSD sensor of strain CCRI-16110 with that of BM4339 revealed point mutations in critical regions of these conserved motifs: (i) a V165A mutation within the H block beside the putative autophosphorylation site and (ii) a Q308K mutation beside the G1 ATP binding block. An intD gene, encoding a putative integrase-like protein showing 99.2% amino acid sequence identity with that of E. faecium BM4339, was found to be associated with the vanD gene cluster (Fig. 1A).
View this table:
[in this window]
[in a new window]
|
TABLE 2. Comparison of nucleotide and amino acid sequences of the vanD gene cluster and intD gene from Ruminococcus sp. strain CCRI-16110 with those of the vanD1, vanD2, vanD3, vanD4, and vanD5 gene clusters
|
Characterization of the vanG-like operon from Ruminococcus sp. strain CCRI-16110.
Since the
ddl gene, encoding the Ddl ligase, is mutated in enterococci
harboring the
vanD gene (
4,
5,
10), we searched for a
ddl gene
in strain CCRI-16110 by using the universal primers V1 and V2a
(Table
1) (
14). A similarity search using TBLASTN revealed that
the sequence of the 630-bp PCR amplification product generated
using these primers encoded a putative protein that was most
similar (66% amino acid sequence identity) to the known VanG
of enterococci, and hence this gene encoding the VanG variant
was designated
vanG like. From this partial
vanG-like gene sequence,
the successive combination of PCR amplification, cloning, and
sequencing allowed us to characterize a 3,950-bp genomic DNA
fragment. Sequence analysis of this genomic DNA fragment revealed
the presence of three complete open reading frames (ORFs) and
one partial ORF encompassing the
vanG-like gene of strain CCRI-16110.
Two complete ORFs displayed the highest amino acid sequence
identities with the VanG
D-Ala-
D-Ser ligases (63.6% to 65.3%)
and the VanT
G serine racemases (58.6 to 59.6%) of the
vanG operons
of enterococci (Table
3). The partial ORF (which resulted from
the shortened PCR fragment used for sequencing) was most similar
to the VanS
G histidine kinase sensors (63.4 to 64.8% identities).
The fourth complete ORF displayed significant amino acid sequence
identity to the VanZ protein encoded in the
vanA operon of
E. faecium BM4147 (27.1%) and the
vanF operon of
Paenibacillus popilliae (27.5%) (Table
3), as well as in the
skin (
sigK intervening
sequence) element of
C. difficile 630 (28.2%). Therefore, the
gene encoding the putative VanZ protein in the
vanG-like cluster
of strain CCRI-16110 was named
vanZG.
View this table:
[in this window]
[in a new window]
|
TABLE 3. Percent identity of the amino acid sequences from the deduced proteins of the vanG-like gene cluster to those from other van gene clusters
|
Comparison of the organization of the partial
vanG-like operon
from strain CCRI-16110 (the region upstream of the
vanSG-like
gene has not been characterized) with those of the
vanG operons
from
E. faecalis BM4518 (
vanG1),
E. faecalis N03-0233 (
vanG2),
and
C. difficile 630 (
vanG like) showed that the genes
vanYG (encoding the carboxypeptidase),
vanXYG (encoding the bifunctional
dipeptidase and carboxypeptidase enzyme), and
vanWG (with unknown
function) were absent in strain CCRI-16110 (Fig.
1B). The
vanZG gene, with unknown function, was present only in the
vanG-like
operon from CCRI-16110 (Fig.
1B). The percent G+C content of
the genes forming the
vanG-like operon of strain CCRI-16110
was higher than that of the
vanG operons from enterococci and
C. difficile (Fig.
1B).
The branching pattern of the phylogenetic tree constructed using sequences of Ddl, D-Ala-D-Ser, and D-Ala-D-Lac ligases showed that the family of D-Ala-D-Ser ligases is organized in three distinct phylogenetic clades that were supported by significant bootstrap resampling values (Fig. 2). Clearly, the VanG-like protein of strain CCRI-16110 was most closely related to the VanG-type D-Ala-D-Ser family of ligases. The two other clades were formed by (i) the VanE and VanC D-Ala-D-Ser ligases and (ii) the D-Ala-D-Ser ligases of Clostridium innocuum.
Transfer of glycopeptide resistance from Ruminococcus sp. strain CCRI-16110 by conjugation.
We performed mating experiments between
Ruminococcus sp. strain
CCRI-16110 and
E. faecalis JH2-2 to determine whether the glycopeptide
resistance of
Ruminococcus sp. strain CCRI-16110 was transferable
by conjugation. No transfer was observed in several mating experiments.

DISCUSSION
We isolated for the first time a potentially novel species of
Ruminococcus (strain CCRI-16110) displaying a high level of
resistance to vancomycin and teicoplanin. This strain was isolated
from a human fecal specimen and harbors the
vanD gene. Work
is in progress to characterize and assign a taxonomic name to
this novel species of
Ruminococcus.
Genetic analysis revealed that Ruminococcus sp. strain CCRI-16110 carries a vanD gene cluster closely related to the vanD1 gene cluster in enterococci. So far, the vanD gene cluster has been described only for enterococci (4, 10, 33), and the present report is the first descriptive study of the vanD gene cluster in a nonenterococcal species.
While searching for a ddl gene in Ruminococcus sp. strain CCRI-16110 and potential alterations in this gene, we identified a cluster of four ORFs, three of which displayed high identities to the vanSG, vanG, and vanTG genes of E. faecalis BM4518 and N03-0233, whereas one ORF was more closely related to the vanZ gene. The vanZ gene has been described in various genetic elements, including the enterococcal vanA operon, the vanF operon of Paenibacillus popilliae, and the skin element of C. difficile 630 (7, 32). The skin element of C. difficile 630 is a 14.66-kb prophage-like element inserted in the gene sigK, encoding a sporulation-specific sigma factor (7, 17, 32). The function of the vanZ gene is unknown, but it was shown to be involved in low-level resistance to teicoplanin in E. faecium BM4147 containing the vanA operon (1, 2).
Phylogenetic analysis showed that the VanG-like ligase of strain CCRI-16110 is closely related to the family of VanG-type D-Ala-D-Ser ligases, suggesting that these proteins share a common ancestor. However, the organization of the vanG operon of this strain differs from that of the vanG operons of enterococci and C. difficile. In CCRI-16110, the vanYG and vanWG genes are absent, while a vanZ-like gene is described for the first time in a vanG-like operon. The presence of the vanUG and vanRG genes as well as the entire sequence of the vanSG gene remains to be characterized in strain CCRI-16110. The percent G+C of the genes forming the vanG-like operon of this strain is higher than those of the vanG operons of enterococci and C. difficile, suggesting different origins for these genes. Therefore, the origin of the vanG and vanG-like operons could be due to a step-by-step mechanism of gene acquisition from various van operons as well as a one-step transfer of the vanG cluster of genes due to mobile genetic elements. Such a one-step acquisition of a vanG cluster was described during the transfer of the vanG operon from E. faecalis BM4518 to E. faecalis JH2-2 and was associated with the movement, from chromosome to chromosome, of genetic elements of ca. 240 kb (9). The transfer of vanG genes could explain the presence of a vanG-like operon in C. difficile 630, considering that this strain harbors several conjugative transposons, including CTn2, CTn4, and CTn5, which have a conjugation module related to that of Tn1549 (32), a conjugative transposon responsible for VanB-type vancomycin resistance (16). It has been shown that the vanG-like operon was not present in all C. difficile strains (32). This observation further supports the horizontal transfer of this operon in C. difficile. Despite the presence of a vanG-like operon in C. difficile 630, this strain is susceptible to glycopeptides (32). Based on these data, we can suggest that the presence of the vanG cluster of genes in some anaerobic bacteria is an evolutionary process towards the expression of glycopeptide resistance.
Ruminococcus sp. strain CCRI-16110 displays a high level of vancomycin and teicoplanin resistance (MICs of both antibiotics, >256 µg/ml), which usually corresponds to the VanA phenotype, although no vanA gene was detected in this strain (data not shown). Therefore, the presence of both vanD and vanG-like operons in Ruminococcus sp. strain CCRI-16110 could be responsible for the high level of resistance to vancomycin and teicoplanin. Moreover, mutations in the VanSD sensor could be responsible for constitutive expression of vancomycin resistance in CCRI-16110, as described for E. faecium BM4339 (10). However, the function of each operon as well as the role of the mutations in vanSD in the vancomycin and teicoplanin resistance phenotype of this strain remains to be described. In addition, the presence of a ddl gene encoding a Ddl ligase in this strain remains to be demonstrated.
The anaerobic bacteria from the intestinal flora seem to represent a reservoir of vanB, vanD, and vanG gene clusters (13) and could be involved in the dissemination of vancomycin resistance genes in other important anaerobic or aerobic gram-positive pathogens. However, in vitro conjugative transfer of the glycopeptide resistance phenotype from Ruminococcus sp. strain CCRI-16110 to E. faecalis JH2-2 could not be demonstrated. While the transfer of the vanG gene cluster has already been described (9), no other vanD gene cluster has been successfully transferred by conjugation in vitro to date (3, 10). The absence of in vitro transfer of the vanD and vanG-like gene clusters in the present study does not rule out the possibility of an in vivo horizontal transfer mechanism that could occur in the intestinal environment. Indeed, the transfer of the vanB gene cluster from Clostridium symbiosum to enterococcal strains has been demonstrated in the gut of gnotobiotic mice (22). Infact, the human gut represents a natural ecosystem where nutrients, biofilm bacteria, antibiotic resistance genes, and genetic material exchange are abundant (29-31).

ACKNOWLEDGMENTS
This study was supported by grant PA-15586 from the Canadian
Institutes of Health Research (CIHR) and by grant 2201-181 from
the Valorisation Recherche Québec (VRQ). M.-C. Domingo
is a research fellow from Bayer Healthcare (Bayer Healthcare/CIHR/AMMI
Canada/FCMI).

FOOTNOTES
* Corresponding author. Mailing address: Centre de Recherche en Infectiologie de l'Université Laval, CHUQ (Pavillon CHUL), 2705 boul. Laurier, Québec, Québec G1V 4G2, Canada. Phone: (418) 654-2705. Fax: (418) 654-2715. E-mail:
michel.g.bergeron{at}crchul.ulaval.ca 
Published ahead of print on 27 August 2007. 

REFERENCES
1 - Arthur, M., F. Depardieu, C. Molinas, P. Reynolds, and P. Courvalin. 1995. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene 154:87-92.[CrossRef][Medline]
2 - Arthur, M., F. Depardieu, P. Reynolds, and P. Courvalin. 1996. Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci. Mol. Microbiol. 21:33-44.[CrossRef][Medline]
3 - Boyd, D. A., P. Kibsey, D. Roscoe, and M. R. Mulvey. 2004. Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance determinant: characterization of the VanD5 operon. J. Antimicrob. Chemother. 54:680-683.[Abstract/Free Full Text]
4 - Boyd, D. A., M. A. Miller, and M. R. Mulvey. 2006. Enterococcus gallinarum N04-0414 harbors a VanD-type vancomycin resistance operon and does not contain a D-alanine:D-alanine 2 (ddl2) gene. Antimicrob. Agents Chemother. 50:1067-1070.[Abstract/Free Full Text]
5 - Casadewall, B., P. E. Reynolds, and P. Courvalin. 2001. Regulation of expression of the vanD glycopeptide resistance gene cluster from Enterococcus faecium BM4339. J. Bacteriol. 183:3436-3446.[Abstract/Free Full Text]
6 - Collins, M. D., P. A. Lawson, A. Willems, J. J. Cordoba, J. Fernandez-Garayzabal, P. Garcia, J. Cai, H. Hippe, and J. A. Farrow. 1994. The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations. Int. J. Syst. Bacteriol. 44:812-826.[Abstract/Free Full Text]
7 - Courvalin, P. 2006. Vancomycin resistance in gram-positive cocci. Clin. Infect. Dis. 42(Suppl. 1):S25-S34.[CrossRef][Medline]
8 - Dalla Costa, L. M., P. E. Reynolds, H. A. Souza, D. C. Souza, M. F. Palepou, and N. Woodford. 2000. Characterization of a divergent vanD-type resistance element from the first glycopeptide-resistant strain of Enterococcus faecium isolated in Brazil. Antimicrob. Agents Chemother. 44:3444-3446.[Abstract/Free Full Text]
9 - Depardieu, F., M. G. Bonora, P. E. Reynolds, and P. Courvalin. 2003. The vanG glycopeptide resistance operon from Enterococcus faecalis revisited. Mol. Microbiol. 50:931-948.[CrossRef][Medline]
10 - Depardieu, F., M. Kolbert, H. Pruul, J. Bell, and P. Courvalin. 2004. VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis. Antimicrob. Agents Chemother. 48:3892-3904.[Abstract/Free Full Text]
11 - Depardieu, F., P. E. Reynolds, and P. Courvalin. 2003. VanD-type vancomycin-resistant Enterococcus faecium 10/96A. Antimicrob. Agents Chemother. 47:7-18.[Abstract/Free Full Text]
12 - Domingo, M. C., A. Huletsky, A. Bernal, R. Giroux, D. K. Boudreau, F. J. Picard, and M. G. Bergeron. 2005. Characterization of a Tn5382-like transposon containing the vanB2 gene cluster in a Clostridium strain isolated from human faeces. J. Antimicrob. Chemother. 55:466-474.[Abstract/Free Full Text]
13 - Domingo, M. C., A. Huletsky, R. Giroux, K. Boissinot, F. J. Picard, P. Lebel, M. J. Ferraro, and M. G. Bergeron. 2005. High prevalence of glycopeptide resistance genes vanB, vanD, and vanG not associated with enterococci in human fecal flora. Antimicrob. Agents Chemother. 49:4784-4786.[Abstract/Free Full Text]
14 - Dutka-Malen, S., C. Molinas, M. Arthur, and P. Courvalin. 1992. Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance. Gene 112:53-58.[CrossRef][Medline]
15 - Engelkirk, P. G., J. Duben-Engelkirk, and J. V. R. Dowell. 1992. Laboratory procedures, p. 331-357. In S. Hoffman (ed.), Principles and practice of clinical anaerobic bacteriology. Star Publishing Company, Belmont, CA.
16 - Garnier, F., S. Taourit, P. Glaser, P. Courvalin, and M. Galimand. 2000. Characterization of transposon Tn1549, conferring VanB-type resistance in Enterococcus spp. Microbiology 146:1481-1489.[Abstract/Free Full Text]
17 - Haraldsen, J. D., and A. L. Sonenshein. 2003. Efficient sporulation in Clostridium difficile requires disruption of the
K gene. Mol. Microbiol. 48:811-821.[CrossRef][Medline] 18 - Jacob, A. E., and S. J. Hobbs. 1974. Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes. J. Bacteriol. 117:360-372.[Abstract/Free Full Text]
19 - Jones, D. T., W. R. Taylor, and J. M. Thornton. 1992. The rapid generation of mutation data matrices from protein sequences. Comput. Appl. Biosci. 8:275-282.[Abstract/Free Full Text]
20 - Ke, D., F. J. Picard, F. Martineau, C. Ménard, P. H. Roy, M. Ouellette, and M. G. Bergeron. 1999. Development of a PCR assay for rapid detection of enterococci. J. Clin. Microbiol. 37:3497-3503.[Abstract/Free Full Text]
21 - Kumar, S., K. Tamura, and M. Nei. 2004. MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief. Bioinform. 5:150-163.[Abstract/Free Full Text]
22 - Launay, A., S. A. Ballard, P. D. Johnson, M. L. Grayson, and T. Lambert. 2006. Transfer of vancomycin resistance transposon Tn1549 from Clostridium symbiosum to Enterococcus spp. in the gut of gnotobiotic mice. Antimicrob. Agents Chemother. 50:1054-1062.[Abstract/Free Full Text]
23 - Leclercq, R., E. Derlot, J. Duval, and P. Courvalin. 1988. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319:157-161.[Medline]
24 - NCCLS. 2004. Methods for antimicrobial susceptibility testing of anaerobic bacteria; approved standard, 6th ed. M11-A6. NCCLS, Wayne, PA.
25 - Périchon, B., B. Casadewall, P. Reynolds, and P. Courvalin. 2000. Glycopeptide-resistant Enterococcus faecium BM4416 is a VanD-type strain with an impaired D-alanine:D-alanine ligase. Antimicrob. Agents Chemother. 44:1346-1348.[Abstract/Free Full Text]
26 - Périchon, B., P. Reynolds, and P. Courvalin. 1997. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob. Agents Chemother. 41:2016-2018.[Abstract]
27 - Rutherford, K., J. Parkhill, J. Crook, T. Horsnell, P. Rice, M. A. Rajandream, and B. Barrell. 2000. Artemis: sequence visualization and annotation. Bioinformatics 16:944-945.[Abstract/Free Full Text]
28 - Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.[Abstract]
29 - Salyers, A. A., A. Gupta, and Y. Wang. 2004. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol. 12:412-416.[CrossRef][Medline]
30 - Salyers, A. A., K. Moon, and M. S. Schlessinger. 2007. The human intestinal tract—a hotbed of resistance gene transfer? Part I. Clin. Microbiol. Newsl. 29:17-21.[CrossRef]
31 - Salyers, A. A., K. Moon, and M. S. Schlessinger. 2007. The human intestinal tract—a hotbed of resistance gene transfer? Part II. Clin. Microbiol. Newsl. 29:25-30.[CrossRef]
32 - Sebaihia, M., B. W. Wren, P. Mullany, N. F. Fairweather, N. Minton, R. Stabler, N. R. Thomson, A. P. Roberts, A. M. Cerdeno-Tarraga, H. Wang, M. T. Holden, A. Wright, C. Churcher, M. A. Quail, S. Baker, N. Bason, K. Brooks, T. Chillingworth, A. Cronin, P. Davis, L. Dowd, A. Fraser, T. Feltwell, Z. Hance, S. Holroyd, K. Jagels, S. Moule, K. Mungall, C. Price, E. Rabbinowitsch, S. Sharp, M. Simmonds, K. Stevens, L. Unwin, S. Whithead, B. Dupuy, G. Dougan, B. Barrell, and J. Parkhill. 2006. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 38:779-786.[CrossRef][Medline]
33 - Tanimoto, K., T. Nomura, H. Maruyama, H. Tomita, N. Shibata, Y. Arakawa, and Y. Ike. 2006. First VanD-type vancomycin-resistant Enterococcus raffinosus isolate. Antimicrob. Agents Chemother. 50:3966-3967.[Free Full Text]
34 - Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.[Abstract/Free Full Text]
35 - Uttley, A. H., C. H. Collins, J. Naidoo, and R. C. George. 1988. Vancomycin-resistant enterococci. Lancet i:57-58.
Antimicrobial Agents and Chemotherapy, November 2007, p. 4111-4117, Vol. 51, No. 11
0066-4804/07/$08.00+0 doi:10.1128/AAC.00584-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Depardieu, F., Foucault, M.-L., Bell, J., Dubouix, A., Guibert, M., Lavigne, J.-P., Levast, M., Courvalin, P.
(2009). New Combinations of Mutations in VanD-Type Vancomycin-Resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium Strains. Antimicrob. Agents Chemother.
53: 1952-1963
[Abstract]
[Full Text]